Proteome Sciences plc (LON:PRM – Get Free Report) reached a new 52-week high during trading on Thursday . The stock traded as high as GBX 5 ($0.06) and last traded at GBX 4.70 ($0.06), with a volume of 157404 shares traded. The stock had previously closed at GBX 4.45 ($0.06).
Proteome Sciences Stock Performance
The stock has a market cap of £11.04 million, a P/E ratio of -374.00 and a beta of 0.07. The firm’s 50 day moving average is GBX 3.25 and its 200 day moving average is GBX 3.15.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Recommended Stories
- Five stocks we like better than Proteome Sciences
- Why Invest in 5G? How to Invest in 5G Stocks
- Bloom Energy: Powering the Future With Decentralized Energy
- Stock Sentiment Analysis: How it Works
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- 3 Monster Growth Stocks to Buy Now
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.